1 December 2015
Abzena raises £20m and announces acquisition
Cambridge, UK, 24 November 2015 - Abzena plc (AIM:ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies enabling the development and manufacture of biopharmaceutical products, has conditionally raised £20 million...
29 October 2015
Catapult secures exit from Systems Integration through Management Buy-Out
Catapult Ventures (“Catapult”) today announced that it has sold its stake in Lichfield-based Systems Integration (Trading) Ltd (‘S.I’) to the company’s management team. Catapult invested in S.I in 2009 alongside the directors of the business and...
8 October 2015
Catapult secures 5.2x cash return after successful exit from Oxford Cryosystems through Management Buy-Out
30 September 2015
£45m Life Sciences Fund Launched at Alderley Park
Today, Manchester Science Partnerships (MSP) announced the launch of a new fund, with a first close of £30.7m, to support growing businesses in the region’s life sciences sector. The announcement was made at the BioCap 2015 conference held at Alderley Park Conference...
16 September 2015
Catapult Ventures announces the acquisition of Lumora by ERBA Diagnostics Mannheim
Catapult Ventures today announced the acquisition of portfolio company Lumora by ERBA Diagnostics Mannheim. Catapult first invested in Lumora, a molecular diagnostics company, in 2011. The initial investment assisted the company progress its existing non-clinical licence...
15 September 2015
Abzena completes PacificGMP acquisition
Strategic acquisition of GMP biopharmaceutical manufacturing capability in the USA extends service and technology offering, enables the capture of more value from projects, and provides wider cross-selling opportunities across the Group … Cambridge, UK and San Diego, CA, USA...
25 August 2015
Lumora Sells Heat Elution Technology to Roche
Cambridgeshire, UK, 24 August 2015 ... Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid Heat Elution purification technology1 to Roche. Roche has signed a definitive Asset...
18 August 2015
BWB completes a second acquisition
BWB is delighted to announce the acquisition of QMP as part of a long term strategic plan to add value and resilience to the BWB Group. Established in 1974, QMP provides building surveying, project management and quantity surveying predominantly to public sector and Higher...
30 July 2015
Oxford BioTherapeutics receives $10 million capital term loan from Silicon Valley Bank
Oxford BioTherapeutics (OBT) today announced the funding of a new capital term loan from Silicon Valley Bank, the bank of the world’s most innovative businesses and their investors. The financing will provide $10 million in capital, with $5 million being funded...
29 July 2015
Biofortuna launches its new approach to custom IVD manufacture and development services
Diagnostics company Biofortuna will mark the 2015 AACC Annual Meeting and Clinical Lab Expo in Atlanta, USA, with the launch of a broader portfolio of custom manufacturing and development services for the IVD market. World-renowned for its lyophilisation services and molecular...